Skip to main navigation Skip to search Skip to main content

Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma

  • Kathrin A Schmohl
  • , Patrick Dolp
  • , Christina Schug
  • , Kerstin Knoop
  • , Kathrin Klutz
  • , Nathalie Schwenk
  • , Peter Bartenstein
  • , Peter J Nelson
  • , Manfred Ogris
  • , Ernst Wagner
  • , Christine Spitzweg

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)1534-1543
    Number of pages10
    JournalThyroid
    Volume27
    Issue number12
    DOIs
    Publication statusPublished - Dec 2017

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • Journal Article
    • anaplastic thyroid carcinoma
    • gene therapy
    • I-131 THERAPY
    • sodium-iodide symporter (NIS)
    • TARGETED RADIOIODINE THERAPY
    • LIVER-CANCER
    • ENHANCED PERMEABILITY
    • RETINOIC ACID
    • radioiodine
    • PROSTATE-CANCER
    • GENE-THERAPY
    • EGFR targeting
    • HEPATOCELLULAR CANCER
    • SYSTEMIC NONVIRAL DELIVERY
    • EXPRESSION

    Fingerprint

    Dive into the research topics of 'Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma'. Together they form a unique fingerprint.

    Cite this